Tagged Articles

fenfluramine 4 articles

New diet drug Qsymia may be rejected by European drug regulators

Qsymia, first diet drug to be approved in 13 years by the U.S. Food and Drug Administration (FDA), may not get clearance from the European Medicines Agency because of the potential for heart problems. A European Union advisory panel is expected to rule on the weight loss treatment sometime next month, but the drug’s maker Vivus Inc. says it has been getting some cold vibes from the group. If rejected, Vivus says it will file a new marketing application or appeal the decision. Vivus wants to market Qsymia in Europe under the name Qsiva. This summer, the FDA approved Qsymia ... Read More

Diet pill indicated as contributing cause of Bubba Smith’s death

Results from an autopsy indicate the diet pill phentermine contributed to the death of Bubba Smith, the towering all-pro football player-turned-actor and commercial spokesman. Smith was also found to have heart disease and high blood pressure. He was 66. The autopsy report listed as a contributing cause of death acute phentermine intoxication, a condition that can cause the heart to beat irregularly and the body to overheat until the person collapses. Phentermine was one ingredient in the diet pill combination “Fen-Phen,” which was pulled from the market after it was shown to cause serious heart risks. Fenfluramine – the “fen” ... Read More

Panel rejects diet drug based on modest results, possible cancer risk

A Food and Drug Administration (FDA) advisory panel voted to reject Arena Pharmaceuticals’ new diet drug, Lorcaserin, because its showed only modest weight loss results in study participants and raised concerns of possible cancer risk. The FDA isn’t required to follow the recommendations of its advisory committee, however it usually does. A final ruling is expected Oct. 22. The panel reviewed studies that showed relatively small amounts of weight loss in patients who took the drug. About half of all patients who stayed in the study for one year lost at least 5 percent of their body weight. Comparatively, about ... Read More

Que She diet pills contain dangerous ingredients that can harm consumers

The herbal weight loss supplement Que She, advertised as “Slimming Factor Capsule” and as “an all-natural blend of Chinese herbs,” widely distributed on Internet sites such as the Bouncing Bear Botanicals website and at retail outlets such as Sacred Journey in Lawrence, Kansas, has been found to contain ingredients that can cause serious harm to consumers, according to an analysis conducted by the Food and Drug Administration (FDA). The active pharmaceutical ingredients include fenfluramine, a stimulant drug withdrawn from the U.S. market in 1997 after studies demonstrated that it caused serious heart valve damage; propranolol, a prescription beta blocker drug ... Read More